Literature DB >> 15713967

Importance of communication between producers and consumers of publicly available experimental data.

Lance A Liotta1, Mark Lowenthal, Arpita Mehta, Thomas P Conrads, Timothy D Veenstra, David A Fishman, Emanuel F Petricoin.   

Abstract

The application of mass spectrometry to discover new cancer biomarkers is in its infancy. Many of these new markers are low-abundance proteins that exist as fragments associated with carrier proteins. Although reproducibility is key to the use of mass spectrometry for ion fingerprint analysis, the scientific community has yet to establish a common platform or standardized operating procedures that are necessary for intra- and inter-laboratory comparison. In an effort to assist others who are perfecting mass spectrometry platforms for profiling, ongoing experimental data were posted for public consumption. An unintended consequence of unrestricted access to experimental data is the risk of inappropriate conclusions drawn and publicly disseminated that could have been avoided by communication between the producers and consumers of the data. Such disputes, however, should not divert us from the validation of this promising new approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713967     DOI: 10.1093/jnci/dji053

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Opportunities and challenges in omics.

Authors:  Mingming Ning; Eng H Lo
Journal:  Transl Stroke Res       Date:  2010-12-01       Impact factor: 6.829

2.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

3.  Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.

Authors:  Lance A Liotta; Emanuel F Petricoin
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 4.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

Review 5.  Transplantation proteomics.

Authors:  Avram Z Traum; Asher D Schachter
Journal:  Pediatr Transplant       Date:  2005-12

6.  Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

Authors:  Pinar B Yildiz; Yu Shyr; Jamshedur S M Rahman; Noel R Wardwell; Lisa J Zimmerman; Bashar Shakhtour; William H Gray; Shuo Chen; Ming Li; Heinrich Roder; Daniel C Liebler; William L Bigbee; Jill M Siegfried; Joel L Weissfeld; Adriana L Gonzalez; Mathew Ninan; David H Johnson; David P Carbone; Richard M Caprioli; Pierre P Massion
Journal:  J Thorac Oncol       Date:  2007-10       Impact factor: 15.609

7.  Statistical Contributions to Bioinformatics: Design, Modeling, Structure Learning, and Integration.

Authors:  Jeffrey S Morris; Veerabhadran Baladandayuthapani
Journal:  Stat Modelling       Date:  2017-06-15       Impact factor: 2.039

8.  Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics.

Authors:  Simon Kaja; Jill D Hilgenberg; Julie L Collins; Anna A Shah; Debra Wawro; Shelby Zimmerman; Robert Magnusson; Peter Koulen
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

9.  Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.

Authors:  Nada Lukkahatai; Sajni Patel; Marjan Gucek; Chao-Pin Hsiao; Leorey N Saligan
Journal:  J Pain Symptom Manage       Date:  2013-07-31       Impact factor: 3.612

10.  Resonant photonic biosensors with polarization-based multiparametric discrimination in each channel.

Authors:  Robert Magnusson; Debra Wawro; Shelby Zimmerman; Yiwu Ding
Journal:  Sensors (Basel)       Date:  2011-01-26       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.